| Field | Row 1 |
|---|---|
| adsh | 0001683168-25-003355 |
| cik | 1748137 |
| name | NEOVOLTA INC. |
| sic | 3690 |
| countryba | US |
| stprba | CA |
| cityba | POWAY |
| zipba | 92064 |
| bas1 | 12195 DEARBORN PLACE |
| bas2 | |
| baph | 800-364-5464 |
| countryma | US |
| stprma | CA |
| cityma | POWAY |
| zipma | 92064 |
| mas1 | 12195 DEARBORN PLACE |
| mas2 | |
| countryinc | US |
| stprinc | NV |
| ein | 825299263 |
| former | NEOVOLTA, INC. |
| changed | 20220613 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0630 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q3 |
| filed | 20250509 |
| accepted | 2025-05-09 16:30:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | neovolta_i10q-033125_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001683168-25-003355 | 20250331 | Additional Paid In Capital | 27919826.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Accounts Receivable Net Current | 1805980.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Assets | 5711691.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 535966.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -988827.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Gross Profit | 514508.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Increase Decrease In Accrued Liabilities | 16826.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 19105.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Interest Expense Nonoperating | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20231231 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20231231 | Net Income Loss | -556044.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20241231 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20250331 | Net Income Loss | -1449331.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20250331 | Operating Expenses | 4215055.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Other Accrued Liabilities Current | 72610.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Proceeds From Lines Of Credit | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Proceeds From Lines Of Credit | 250000.0000 | USD | 0 | us-gaap/2024 | Transaction Type= Commercial Lender; | ||
| 0001683168-25-003355 | 20250331 | Proceeds From Lines Of Credit | 2081845.0000 | USD | 3 | us-gaap/2024 | Transaction Type= Commercial Lender; | ||
| 0001683168-25-003355 | 20240331 | Proceeds From Warrant Exercises | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3675922.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Share Based Compensation | 81683.0000 | USD | 3 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Counterparty Name= Three Officers And Two Other Individuals; | ||
| 0001683168-25-003355 | 20250331 | Share Based Compensation | 693622.0000 | USD | 3 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Counterparty Name= Three Officers And Two Other Individuals; | ||
| 0001683168-25-003355 | 20230930 | Shares Outstanding | 33155127.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20230930 | Stockholders Equity | 6122375.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Stockholders Equity | 33246.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20241231 | Stockholders Equity | -22678169.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20250331 | Stockholders Equity | 34125.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 164250.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value Share Based Compensation | 888330.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value Share Based Compensation | 164.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 33226411.0000 | shares | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Assets Current | 4656530.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 986427.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Common Stock Shares Issued | 34124873.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Earnings Per Share Basic | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Earnings Per Share Basic | -0.0400 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Earnings Per Share Diluted | -0.1000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | General And Administrative Expense | 756118.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Gross Profit | 493190.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Increase Decrease In Inventories | 492417.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Interest Expense Nonoperating | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Liabilities | 1885240.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Liabilities Current | 1501702.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Line Of Credit | 1420116.0000 | USD | 0 | us-gaap/2024 | Transaction Type= Commercial Lender; | ||
| 0001683168-25-003355 | 20230930 | Net Income Loss | -428715.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20231231 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20250331 | Nonoperating Income Expense | -101173.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Operating Expenses | 766510.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Operating Income Loss | -1603178.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Operating Income Loss | -1370970.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Proceeds From Short Term Debt | 2081845.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Repayments Of Lines Of Credit | 116462.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Research And Development Expense | 27947.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230630 | Stockholders Equity | -18439228.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20230930 | Stockholders Equity | 24957163.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240630 | Stockholders Equity | 33236.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240930 | Stockholders Equity | -21707032.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20241231 | Stockholders Equity | 3300288.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241231 | Stockholders Equity | 25945040.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20241231 | Stockholders Equity | 33417.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240930 | Stock Issued During Period Shares Share Based Compensation | 9776.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Shares Share Based Compensation | 115844.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value New Issues | 1087000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Stock Issued During Period Value Share Based Compensation | 84717.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Stock Issued During Period Value Share Based Compensation | 84717.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20230930 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20230930 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20240331 | Stock Issued During Period Value Share Based Compensation | 63638.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 33640829.0000 | shares | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Assets Current | 5711691.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Cash And Cash Equivalents At Carrying Value | 986427.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -450461.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Common Stock Value | 34125.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Cost Of Goods And Services Sold | 117755.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Earnings Per Share Diluted | -0.0400 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Increase Decrease In Accounts Payable | 3167.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Increase Decrease In Inventories | -443624.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Inventory Net | 1787308.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20241231 | Net Income Loss | -971137.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20250331 | Net Income Loss | -3384962.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Operating Income Loss | -3283789.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Prepaid Expense And Other Assets Current | 539532.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Proceeds From Issuance Of Private Placement | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Proceeds From Lines Of Credit | 500000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Proceeds From Warrant Exercises | 160400.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Provision For Doubtful Accounts | 238441.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Repayments Of Lines Of Credit | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Research And Development Expense | 10392.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Retained Earnings Accumulated Deficit | -20742538.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Retained Earnings Accumulated Deficit | -24127500.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230630 | Shares Outstanding | 33155127.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240630 | Shares Outstanding | 33236091.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Shares Outstanding | 34124873.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20230930 | Stockholders Equity | 33155.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20231231 | Stockholders Equity | -19423987.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20240331 | Stockholders Equity | -20013460.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20240630 | Stockholders Equity | -20742538.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Shares Conversion Of Convertible Securities | 55412.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20220831 | Stock Issued During Period Shares New Issues | 1121250.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Units; Subsidiary Sale Of Stock= Underwritten Public Offering; | ||
| 0001683168-25-003355 | 20231231 | Stock Issued During Period Value Share Based Compensation | 97141.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20231231 | Stock Issued During Period Value Share Based Compensation | 97060.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240331 | Stock Issued During Period Value Share Based Compensation | 63638.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240930 | Stock Issued During Period Value Share Based Compensation | 265399.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Share Based Compensation | 214690.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Share Based Compensation | 214574.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20240630 | Assets | 4656530.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Cost Of Goods And Services Sold | 2744656.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | General And Administrative Expense | 4136167.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 462717.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Liabilities Current | 61100.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Net Income Loss | -428715.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20231231 | Net Income Loss | -556044.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Operating Income Loss | -600365.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Proceeds From Issuance Of Private Placement | 1087000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Repayments Of Lines Of Credit | 661729.0000 | USD | 3 | us-gaap/2024 | Transaction Type= Commercial Lender; | ||
| 0001683168-25-003355 | 20250331 | Research And Development Expense | 78888.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Share Based Compensation | 245496.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20231231 | Shares Outstanding | 33236091.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240331 | Shares Outstanding | 33236091.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240630 | Short Term Borrowings | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Stockholders Equity | 5137637.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Stockholders Equity | -24127500.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value New Issues | 1086456.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 33640829.0000 | shares | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Accounts Payable Current | 5316.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Additional Paid In Capital | 25304732.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Earnings Per Share Basic | -0.0500 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Earnings Per Share Diluted | -0.0500 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Gross Profit | 166145.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Income Taxes Paid Net | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Increase Decrease In Accounts Receivable | 730170.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Interest Expense Nonoperating | 103045.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Inventory Net | 2279725.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Liabilities And Stockholders Equity | 4656530.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Line Of Credit | 383538.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Net Income Loss | -589473.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20240930 | Net Income Loss | -964494.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20240331 | Proceeds From Short Term Debt | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Provision For Doubtful Accounts | 670000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Research And Development Expense | 10392.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20231231 | Stockholders Equity | 5663472.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20231231 | Stockholders Equity | 33236.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240630 | Stockholders Equity | 4595430.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Stockholders Equity | 3896335.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Conversion Of Convertible Securities | 55.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value New Issues | 544.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20231231 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 33205766.0000 | shares | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Accounts Receivable Net Current | 2356468.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1013962.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001683168-25-003355 | 20240630 | Common Stock Shares Issued | 33236091.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Common Stock Shares Outstanding | 33236091.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Common Stock Shares Outstanding | 34124873.0000 | shares | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Common Stock Value | 33236.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Cost Of Goods And Services Sold | 1499597.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Earnings Per Share Diluted | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Gross Profit | 931266.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Increase Decrease In Accounts Receivable | 788929.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Interest And Other Income | 10892.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Interest And Other Income | 138.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Interest And Other Income | 1872.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Interest Paid Net | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Line Of Credit | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Net Cash Provided By Used In Financing Activities | 3051054.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Net Cash Provided By Used In Operating Activities | -3501515.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Net Income Loss | -964494.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20241231 | Net Income Loss | -971137.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Nonoperating Income Expense | 28946.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Operating Expenses | 1885478.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241130 | Proceeds From Warrant Exercises | 160400.0000 | USD | 0 | us-gaap/2024 | Award Type= Warrants; | ||
| 0001683168-25-003355 | 20240331 | Repayments Of Short Term Debt | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2065858.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2014105.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Share Based Compensation | 1368583.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Shares Outstanding | 33245867.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20241231 | Shares Outstanding | 33417123.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Short Term Borrowings | 1420116.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230930 | Stockholders Equity | -18867943.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001683168-25-003355 | 20240331 | Stockholders Equity | 25117861.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240630 | Stockholders Equity | 25304732.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20250331 | Stockholders Equity | 27919826.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20231231 | Stock Issued During Period Shares Share Based Compensation | 80964.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Conversion Of Convertible Securities | 160400.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20231231 | Stock Issued During Period Value Share Based Compensation | 81.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240930 | Stock Issued During Period Value Share Based Compensation | 265389.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2002789.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Cost Of Goods And Services Sold | 1572668.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Earnings Per Share Basic | -0.1000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | General And Administrative Expense | 2085976.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Income Taxes Paid Net | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Increase Decrease In Accounts Payable | 3660.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Increase Decrease In Accrued Liabilities | -27607.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Interest Expense Nonoperating | 78499.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Liabilities | 61100.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20240331 | Net Income Loss | -1574232.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Operating Expenses | 2096368.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Prepaid Expense And Other Assets Current | 76815.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Repayments Of Short Term Debt | 661729.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230630 | Stockholders Equity | 6466373.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230630 | Stockholders Equity | 24872446.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20231231 | Stockholders Equity | 25054223.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240331 | Stockholders Equity | 33236.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240930 | Stockholders Equity | 25570121.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20250331 | Stockholders Equity | 3826451.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Conversion Of Convertible Securities | 160345.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001683168-25-003355 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20240930 | Stock Issued During Period Value Share Based Compensation | 10.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 33205766.0000 | shares | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 33412117.0000 | shares | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Accounts Payable Current | 8976.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Cash And Cash Equivalents At Carrying Value | 535966.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001683168-25-003355 | 20240630 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | General And Administrative Expense | 1857531.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Interest And Other Income | 28946.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Interest Paid Net | 22845.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Liabilities And Stockholders Equity | 5711691.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Net Cash Provided By Used In Operating Activities | -988827.0000 | USD | 3 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Net Income Loss | -589473.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240930 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20241231 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001683168-25-003355 | 20250331 | Net Income Loss | -1449331.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001683168-25-003355 | 20240331 | Nonoperating Income Expense | 10892.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Nonoperating Income Expense | -78361.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240630 | Other Accrued Liabilities Current | 55784.0000 | USD | 0 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Other Accrued Liabilities Current | 146250.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Two Directors; | ||
| 0001683168-25-003355 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 283900.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20230630 | Stockholders Equity | 33155.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Shares New Issues | 543500.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20240930 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001683168-25-003355 | 20241231 | Stock Issued During Period Value Share Based Compensation | 116.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001683168-25-003355 | 20250331 | Stock Issued During Period Value Share Based Compensation | 888494.0000 | USD | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 33226411.0000 | shares | 1 | us-gaap/2024 | |||
| 0001683168-25-003355 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 33412117.0000 | shares | 3 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Repayments Of Short Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Short-Term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Line Of Credit | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Line of Credit | The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Interest And Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Short Term Borrowings | us-gaap/2024 | 0 | 0 | monetary | I | C | Short-Term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Proceeds From Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Lines of Credit | Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Proceeds From Short Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Short-Term Debt | The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Repayments Of Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Lines of Credit | Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001683168-25-003355 | 6 | 12 | CF | 0 | H | Repayments Of Lines Of Credit | us-gaap/2024 | Repayments of line of credit | 1 |
| 0001683168-25-003355 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001683168-25-003355 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001683168-25-003355 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory, net | 0 |
| 0001683168-25-003355 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid insurance and other current assets | 0 |
| 0001683168-25-003355 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001683168-25-003355 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001683168-25-003355 | 2 | 9 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001683168-25-003355 | 2 | 10 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2024 | Accrued liabilities | 0 |
| 0001683168-25-003355 | 2 | 11 | BS | 0 | H | Short Term Borrowings | us-gaap/2024 | Short-term notes payable | 0 |
| 0001683168-25-003355 | 2 | 12 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001683168-25-003355 | 2 | 13 | BS | 0 | H | Line Of Credit | us-gaap/2024 | Payable to line of credit lender | 0 |
| 0001683168-25-003355 | 2 | 14 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001683168-25-003355 | 2 | 15 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 4) | 0 |
| 0001683168-25-003355 | 2 | 16 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value, 100,000,000 shares authorized, 34,124,873 and 33,236,091 shares, respectively, issued and outstanding | 0 |
| 0001683168-25-003355 | 2 | 17 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001683168-25-003355 | 2 | 18 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001683168-25-003355 | 2 | 19 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001683168-25-003355 | 2 | 20 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0001683168-25-003355 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001683168-25-003355 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001683168-25-003355 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001683168-25-003355 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001683168-25-003355 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Revenues from contracts with customers | 0 |
| 0001683168-25-003355 | 4 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of goods sold | 0 |
| 0001683168-25-003355 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001683168-25-003355 | 4 | 4 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001683168-25-003355 | 4 | 5 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001683168-25-003355 | 4 | 6 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001683168-25-003355 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001683168-25-003355 | 4 | 8 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001683168-25-003355 | 4 | 9 | IS | 0 | H | Interest And Other Income | us-gaap/2024 | Interest income | 0 |
| 0001683168-25-003355 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense) | 0 |
| 0001683168-25-003355 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001683168-25-003355 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding - basic | 0 |
| 0001683168-25-003355 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding - diluted | 0 |
| 0001683168-25-003355 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share - basic | 0 |
| 0001683168-25-003355 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share - diluted | 0 |
| 0001683168-25-003355 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance, value | 0 |
| 0001683168-25-003355 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0001683168-25-003355 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Stock compensation expense | 0 |
| 0001683168-25-003355 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock compensation expense, shares | 0 |
| 0001683168-25-003355 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Exercise of common stock warrants | 0 |
| 0001683168-25-003355 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Exercise of common stock warrants, shares | 0 |
| 0001683168-25-003355 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock in private offering | 0 |
| 0001683168-25-003355 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock in private offering, shares | 0 |
| 0001683168-25-003355 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001683168-25-003355 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance, value | 0 |
| 0001683168-25-003355 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0001683168-25-003355 | 6 | 1 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001683168-25-003355 | 6 | 2 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock compensation expense | 0 |
| 0001683168-25-003355 | 6 | 3 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Provision for expected credit losses/bad debt expense | 0 |
| 0001683168-25-003355 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001683168-25-003355 | 6 | 5 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001683168-25-003355 | 6 | 6 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid insurance and other current assets | 1 |
| 0001683168-25-003355 | 6 | 7 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001683168-25-003355 | 6 | 8 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001683168-25-003355 | 6 | 9 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash flows used in operating activities | 0 |
| 0001683168-25-003355 | 6 | 10 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Proceeds of private equity offering | 0 |
| 0001683168-25-003355 | 6 | 11 | CF | 0 | H | Proceeds From Lines Of Credit | us-gaap/2024 | Borrowings under line of credit | 0 |
| 0001683168-25-003355 | 6 | 13 | CF | 0 | H | Proceeds From Short Term Debt | us-gaap/2024 | Borrowings under short-term notes payable | 0 |
| 0001683168-25-003355 | 6 | 14 | CF | 0 | H | Repayments Of Short Term Debt | us-gaap/2024 | Repayments of short-term notes payable | 1 |
| 0001683168-25-003355 | 6 | 15 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from exercise of common stock warrants | 0 |
| 0001683168-25-003355 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash flows provided by financing activities | 0 |
| 0001683168-25-003355 | 6 | 17 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net decrease in cash and cash equivalents | 0 |
| 0001683168-25-003355 | 6 | 18 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001683168-25-003355 | 6 | 19 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001683168-25-003355 | 6 | 21 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001683168-25-003355 | 6 | 22 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income taxes | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |